Literature DB >> 22725134

HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

Judd F Hultquist1, Rebecca M McDougle, Brett D Anderson, Reuben S Harris.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) requires the cellular transcription factor core binding factor subunit β (CBFβ) to stabilize its viral infectivity factor (Vif) protein and neutralize the APOBEC3 restriction factors. CBFβ normally heterodimerizes with the RUNX family of transcription factors, enhancing their stability and DNA-binding affinity. To test the hypothesis that Vif may act as a RUNX mimic to bind CBFβ, we generated a series of CBFβ mutants at the RUNX/CBFβ interface and tested their ability to stabilize Vif and impact transcription at a RUNX-dependent promoter. While several CBFβ amino acid substitutions disrupted promoter activity, none of these impacted the ability of CBFβ to stabilize Vif or enhance degradation of APOBEC3G. A mutagenesis screen of CBFβ surface residues identified a single amino acid change, F68D, that disrupted Vif binding and its ability to degrade APOBEC3G. This mutant still bound RUNX and stimulated RUNX-dependent transcription. These separation-of-function mutants demonstrate that HIV-1 Vif and the RUNX transcription factors interact with cellular CBFβ on genetically distinct surfaces.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22725134      PMCID: PMC3505047          DOI: 10.1089/AID.2012.0142

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  39 in total

1.  Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.

Authors:  Y Y Tang; B E Crute; J J Kelley; X Huang; J Yan; J Shi; K L Hartman; T M Laue; N A Speck; J H Bushweller
Journal:  FEBS Lett       Date:  2000-03-24       Impact factor: 4.124

2.  The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.

Authors:  J Bravo; Z Li; N A Speck; A J Warren
Journal:  Nat Struct Biol       Date:  2001-04

3.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

Review 4.  Structural and functional characterization of Runx1, CBF beta, and CBF beta-SMMHC.

Authors:  Lina Zhang; Stephen M Lukasik; Nancy A Speck; John H Bushweller
Journal:  Blood Cells Mol Dis       Date:  2003 Mar-Apr       Impact factor: 3.039

5.  Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.

Authors:  T Nagata; M H Werner
Journal:  J Mol Biol       Date:  2001-04-27       Impact factor: 5.469

6.  Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.

Authors:  T H Tahirov; T Inoue-Bungo; H Morii; A Fujikawa; M Sasaki; K Kimura; M Shiina; K Sato; T Kumasaka; M Yamamoto; S Ishii; K Ogata
Journal:  Cell       Date:  2001-03-09       Impact factor: 41.582

7.  Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.

Authors:  G Huang; K Shigesada; K Ito; H J Wee; T Yokomizo; Y Ito
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

8.  Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

Authors:  E Ogawa; M Inuzuka; M Maruyama; M Satake; M Naito-Fujimoto; Y Ito; K Shigesada
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

Review 9.  Core-binding factors in hematopoiesis and immune function.

Authors:  Marella F T R de Bruijn; Nancy A Speck
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

10.  Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.

Authors:  Xiaohong Zhou; Sean L Evans; Xue Han; Yayan Liu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more
  23 in total

Review 1.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

2.  Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.

Authors:  Ke Zhao; Juan Du; Yajuan Rui; Wenwen Zheng; Jian Kang; Jingwei Hou; Kang Wang; Wenyan Zhang; Viviana A Simon; Xiao-Fang Yu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.

Authors:  Juan Du; Ke Zhao; Yajuan Rui; Peng Li; Xiaohong Zhou; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

4.  Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Authors:  Youwei Ai; Dantong Zhu; Cuihui Wang; Chao Su; Jian Ma; Jianzhang Ma; Xiaojun Wang
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.

Authors:  Yingying Guo; Liyong Dong; Xiaolin Qiu; Yishu Wang; Bailing Zhang; Hongnan Liu; You Yu; Yi Zang; Maojun Yang; Zhiwei Huang
Journal:  Nature       Date:  2014-01-09       Impact factor: 49.962

6.  Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Katsuhiro Io; Kohei Tada; Fumie Iwai; Masayuki Kobayashi; Norimitsu Kadowaki; Reuben S Harris; Akifumi Takaori-Kondo
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

7.  Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.

Authors:  Xiaohong Zhou; Xue Han; Ke Zhao; Juan Du; Sean L Evans; Hong Wang; Peng Li; Wenwen Zheng; Yajuan Rui; Jian Kang; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

8.  A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.

Authors:  Sizhu Duan; Shiqi Wang; Yanan Song; Nan Gao; Lina Meng; Yanxin Gai; Ying Zhang; Song Wang; Chu Wang; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

9.  CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Authors:  Eri Miyagi; Sandra Kao; Venkat Yedavalli; Klaus Strebel
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.

Authors:  Dong Young Kim; Eunju Kwon; Paul D Hartley; David C Crosby; Sumanjit Mann; Nevan J Krogan; John D Gross
Journal:  Mol Cell       Date:  2013-01-17       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.